See how your reported results read as versioned evidence records — linked to experiments and limitations.Know what the science actually supports before you trust the answer.
Press Enter ↵ to review claims
Explore by Goal
"The cosmos is within us. We are made of star-stuff. We are a way for the universe to know itself."
Evidence from cited, peer-reviewed biomedical outputs (e.g., cholera/typhoid vaccine effectiveness and endemicity analyses) suggests solid engagement with clinical/public-health study design; however, the provided record is incomplete and contains topic-domain ambiguity, so a full, publication-grade assessment requires verified bibliographic disambiguation and full-text review.
Long Explanation
BGPT Author Review — Nirmal Kumar Ganguly
Scope & skepticism. The input provides mixed bibliographic signals (some items appear non-biomedical, and some author-name variants exist in indexing). I therefore treat topic-domain assignments, authorship attribution, and study-method claims as unverified unless supported by a provided DOI/full record. Wherever possible, I ground statements in the DOI-tagged paper(s) explicitly present in your data.
Grounded evidence (only from explicitly provided DOI-linked sources): The provided endemicity/hotspot report describes substantial surveillance underreporting and uses spatial hotspot mapping to identify high-risk districts, reporting 78 hotspots, 111 high-risk districts, and 641 districts surveyed for the hotspot mapping period, alongside 68 outbreaks (1997–2006). These numeric extractions are taken from the provided description associated with DOI 10.1093/infdis/jiab436.
These values are taken from the provided extraction text, not re-computed from raw trial-level data.
Evidence-strength note. The efficacy numbers shown here reflect textually extracted values included in the provided summary tied to DOI 10.1093/infdis/jiab436, which is plausibly a synthesis/supplement rather than a single new efficacy trial, so direct causal strength depends on the underlying referenced trials.
What the provided DOI-linked record supports (and what it doesn’t)
1) Clinical/public-health evidence on enteric infections & vaccines.
A DOI-linked record in your OpenAlex excerpt includes major randomized/cluster-randomized vaccine effectiveness work (e.g., typhoid Vi vaccine in a cluster-randomized effectiveness setting; cholera vaccine interim analysis in a Lancet cluster-randomized double-blind placebo-controlled design).
2) Scientific communication through synthesis/strategic argumentation.
The cholera endemicity hotspot report frames an argument linking surveillance gaps, spatial risk structure, and the need for targeted prevention strategy. That style can be scientifically valuable when it is transparent about data limitations and uncertainty—but it depends on the supplement’s methodological rigor and representativeness of underlying datasets.
3) Broader medical/public-health framing (beyond a single organism).
Your provided OpenAlex excerpt also includes items such as a Science paper on health innovation networks to address neglected diseases and a clinical study of miltefosine for visceral leishmaniasis (both DOI-tagged in the excerpt). These suggest capacity to operate across infectious diseases and translational strategy.
Publication activity over time (from provided OpenAlex excerpt)
This plot is based only on the year-wise counts present in your excerpt; it is not a DOI-based claim about any specific paper’s methods.
Critical caveat. Without the underlying disambiguated publication list, these year-wise counts can reflect database disambiguation artifacts, author-name conflation, or time-dependent indexing. Treat them as activity metadata, not as a validated measure of scientific quality.
Scientific strength assessment (based strictly on the provided evidence)
Strength — evidence-based infectious-disease work. Provided DOI-linked items include high-quality randomized/cluster-randomized trial designs for enteric infections and clinical evaluation for parasitic disease, which generally require rigorous protocol implementation and statistical planning.
Strength — synthesis of surveillance + spatial risk structure. The cholera hotspot report explicitly frames underreporting and uses spatial mapping to locate endemic hot zones, which is aligned with scientifically defensible epidemiological modeling when the limitations are acknowledged.
Red flag — record completeness and author disambiguation. The provided “papers” list includes non-biomedical titles (e.g., software/copyright, WiFi QoS), which suggests either dataset contamination or author-name conflation. Without verified full-text and reliable author IDs, attributing scientific rigor across domains is not scientifically safe.
What could disprove/adjust the assessment (falsification targets):
If full-text review of the DOI-linked clinical trials reveals major bias risks (e.g., poor blinding integrity, differential loss to follow-up, flawed cluster handling) or if the cholera synthesis uses inconsistent case definitions/data linkages, then the inferred scientific strength would drop.
For the cholera supplement specifically, if independent surveillance systems show that the reported hotspot/district risk pattern disappears after correcting underreporting and changing administrative mappings, then the strategy for hotspot targeting would be undermined.
Useful BGPT next steps
Feedback:
Updated: April 06, 2026
BGPT Author Review
Scientific Quality
60%
Based on the provided DOI-linked biomedical record, the strongest evidence is participation in high-quality vaccine effectiveness trial designs (cluster-randomized, double-blind, placebo-controlled; NEJM/Vaccine trial contexts), plus surveillance/spatial synthesis work for cholera. However, the supplied “papers” list includes clearly non-biomedical topics, implying likely author-name conflation or dataset contamination. Without a fully verified publication list and full-text appraisal, rigor and biological specificity cannot be safely credited across the entire output. Citation metrics are split/conflicting between datasets, further weakening attribution confidence.
Communication Quality
60%
The provided inputs include structured trial-oriented and supplement-style synthesis work, suggesting ability to communicate methods and outcomes. But there is insufficient full-text content here to judge clarity, precision in uncertainty reporting, or how well arguments avoid overclaiming relative to the data.
Author Novelty
50%
The record suggests applied/implementation novelty (e.g., integrating surveillance with spatial hotspot mapping; vaccine effectiveness in real-world settings). However, without full-text innovation details or method comparison to prior work, novelty relative to the field remains uncertain.
Scientific Rigor
60%
Trial designs referenced by DOI are generally rigorous in principle, and the cholera supplement appears to acknowledge surveillance limitations. Yet rigorous scoring is limited by incomplete verification (authorship disambiguation, full-text availability, and whether statistical/cluster methods are correctly executed) and by potential dataset contamination/non-bio items.
I would extract hotspot counts and vaccine-efficacy fields from the provided DOI-linked cholera synthesis text, then plot stability/sensitivity summaries and generate a structured evidence table for quick method critique.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
Hotspots identified purely from reported case counts are unbiased estimates of true transmission hotspots without any correction for differential healthcare access or reporting—unlikely given the report’s underreporting emphasis.
Cluster-randomized vaccine effectiveness results are fully portable across regions regardless of surveillance intensity and implementation fidelity—unlikely when endpoint ascertainment depends on local reporting.
Science Art
Science Movie
Make a narrated HD Science movie for this answer ($32 per minute)
Explore by Goal
Quick Explanation
Long Explanation
Top Data Sources
Ask a Follow-Up
Key Insight
Keep Exploring
Analysis 
Hypothesis Graveyard
Discussion